Roy Freeman
- Neurology top 0.05%
- Botulinum Toxin and Related Neurological Disorders 71
- Parkinson's Disease Mechanisms and Treatments 46
- Neurological disorders and treatments 21
- Physiology top 0.05%
- Pain Mechanisms and Treatments 57
-
- Heart Rate Variability and Autonomic Control 59
- Neurology top 0.5%
- Botulinum Toxin and Related Neurological Disorders 71
- Parkinson's Disease Mechanisms and Treatments 46
- Neurological disorders and treatments 21
-
- Cardiovascular Syncope and Autonomic Disorders 70
-
- Genetic Neurodegenerative Diseases 13
-
- Cancer Treatment and Pharmacology 13
- Co-authors
- Aaron I. VinikChristopher H. GibbonsRaelene E. MaserAndrew J.M. BoultonRayaz A. MalikBraxton D. MitchellDan ZieglerEva L. Feldman
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Roy Freeman
203 papers receiving 18.7k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Neurology 6.9k
- Physiology 8.4k
- Cardiology and Cardiovascular Medicine 5.8k
- Neurology 1.4k
- Endocrinology, Diabetes and Metabolism 2.6k
Countries citing papers authored by Roy Freeman
This map shows the geographic impact of Roy Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Freeman more than expected).
Fields of papers citing papers by Roy Freeman
This network shows the impact of papers produced by Roy Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Freeman. The network helps show where Roy Freeman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roy Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 13 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 18 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 52 | |
| 6 | 2018 | 47 | |
| 7 | 2018 | 168 | |
| 8 | 2017 | 55 | |
| 9 | 2017 | 12 | |
| 10 | 2017 | 204 | |
| 11 | 2015 | 103 | |
| 12 | 2014 | 2 | |
| 13 | 2006 | 31 | |
| 14 | 2005 | 162 | |
| 15 | 2004 | 19 | |
| 16 | 2002 | 7 | |
| 17 | 2002 | 4 | |
| 18 | 2000 | 274 | |
| 19 | 1996 | 25 | |
| 20 | 1993 | 25 |
About Roy Freeman
Roy Freeman is a scholar working on Neurology, Physiology and Cardiology and Cardiovascular Medicine, having authored 206 papers that have together received 19.5k indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (71 papers), Cardiovascular Syncope and Autonomic Disorders (70 papers), Heart Rate Variability and Autonomic Control (59 papers), Pain Mechanisms and Treatments (57 papers), Parkinson's Disease Mechanisms and Treatments (46 papers), Neurological disorders and treatments (21 papers), Genetic Neurodegenerative Diseases (13 papers) and Cancer Treatment and Pharmacology (13 papers). The work is most often cited by research in Neurology (6.9k citations), Physiology (8.4k citations) and Cardiology and Cardiovascular Medicine (5.8k citations). Roy Freeman has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Aaron I. Vinik, Christopher H. Gibbons, Raelene E. Maser, Andrew J.M. Boulton, Rayaz A. Malik, Braxton D. Mitchell, Dan Ziegler, Eva L. Feldman, Vera Bril and Jay M. Sosenko. Their work appears in journals such as Neurology, Clinical Autonomic Research, Diabetes Care, Pain and Muscle & Nerve.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.